Application of risk factors for venous thromboembolism in patients with multiple myeloma starting chemotherapy, a real-world evaluation.

Hailey A BakerAlexandra R BrownJonathan D MahnkenTheresa I ShiremanCarol E WebbBrea C Lipe

Published in: Cancer medicine (2018)

Our results suggest that IMWG guidelines are not being consistently followed and therefore could not be validated. Additional risk factors were not identified, but risk for VTE may change over time suggesting patients may require ongoing assessment of VTE risk and thromboprophylaxis throughout the disease course.

Keyphrases

venous thromboembolism
direct oral anticoagulants
risk factors
multiple myeloma
end stage renal disease
newly diagnosed
ejection fraction
peritoneal dialysis
prognostic factors
locally advanced
radiation therapy
squamous cell carcinoma
patient reported outcomes
atrial fibrillation